Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8 + TIL infiltration, and provides no independent prognostic value in endometriosis‐associated ovarian carcinomas
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Validated biomarker assays confirm that
ARID1A
loss is confounded with
MMR
deficiency,
CD8
+
TIL
infiltration, and provides no independent prognostic value in endometriosis‐associated ovarian carcinomas
Authors
Keywords
-
Journal
JOURNAL OF PATHOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-12-13
DOI
10.1002/path.5849
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ARID1A regulates R-loop associated DNA replication stress
- (2021) Shuhe Tsai et al. PLoS Genetics
- Treatment Strategies for ARID1A-Deficient Ovarian Clear Cell Carcinoma
- (2021) Kazuaki Takahashi et al. Cancers
- Accurate Distinction of Ovarian Clear Cell From Endometrioid Carcinoma Requires Integration of Phenotype, Immunohistochemical Predictions, and Genotype
- (2021) Monica Rodriguez et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- ARID1A mutation/ARID1A loss is associated with a high immunogenic profile in clear cell ovarian cancer
- (2021) Yuka Kuroda et al. GYNECOLOGIC ONCOLOGY
- Molecular Heterogeneity of Endometrioid Ovarian Carcinoma
- (2020) Susanna Leskela et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma
- (2020) Pauline Krämer et al. CLINICAL CANCER RESEARCH
- ARID1A mutations and expression loss in non-small cell lung carcinomas: clinicopathologic and molecular analysis
- (2020) Yin P. Hung et al. MODERN PATHOLOGY
- Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses
- (2020) Eun Young Kang et al. MODERN PATHOLOGY
- Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report
- (2020) Yu-Chien Lin et al. Journal of Ovarian Research
- Prevalence of Lynch syndrome in women with mismatch repair‐deficient ovarian cancer
- (2020) Rachel Hodan et al. Cancer Medicine
- Clinicopathological correlation of ARID1A status with HDAC6 and its related factors in ovarian clear cell carcinoma
- (2019) Mitsutake Yano et al. Scientific Reports
- Targeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers
- (2019) Hideaki Ogiwara et al. CANCER CELL
- Antitumor Activity and Safety of Pembrolizumab in Patients with Advanced Recurrent Ovarian Cancer: Results from the Phase 2 KEYNOTE-100 Study
- (2019) U A Matulonis et al. ANNALS OF ONCOLOGY
- Loss of ARID1A promotes proliferation, migration and invasion via the Akt signaling pathway in NPC
- (2019) Yang Yang et al. Cancer Management and Research
- Diagnostic and prognostic value of ARID1A in endometrial hyperplasia: a novel marker of occult cancer
- (2019) Antonio Raffone et al. APMIS
- Relationship between Microsatellite Instability, Immune Cells Infiltration, and Expression of Immune Checkpoint Molecules in Ovarian Carcinoma: Immunotherapeutic Strategies for the Future
- (2019) Hitomi Yamashita et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Analysis of gene expression signatures identifies prognostic and functionally distinct ovarian clear cell carcinoma subtypes
- (2019) Tuan Zea Tan et al. EBioMedicine
- Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups
- (2018) Tjalling Bosse et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers
- (2018) Cécile Le Page et al. BMC CANCER
- ARID1A ablation leads to multiple drug resistance in ovarian cancer via transcriptional activation of MRP2
- (2018) Qingyu Luo et al. CANCER LETTERS
- Mismatch repair deficiency is associated with MSI phenotype, increased tumor-infiltrating lymphocytes and PD-L1 expression in immune cells in ovarian cancer
- (2018) Xue Xiao et al. GYNECOLOGIC ONCOLOGY
- Ovarian Carcinoma Histotype
- (2018) Martin Köbel et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma
- (2018) Emi Sato et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- High-level expression of ARID1A predicts a favourable outcome in triple-negative breast cancer patients receiving paclitaxel-based chemotherapy
- (2018) Yuan-Feng Lin et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade
- (2018) Jianfeng Shen et al. NATURE MEDICINE
- The ARID1A, p53 and ß-Catenin statuses are strong prognosticators in clear cell and endometrioid carcinoma of the ovary and the endometrium
- (2018) Marlene Heckl et al. PLoS One
- ARID1A-deficiency in urothelial bladder cancer: No predictive biomarker for EZH2-inhibitor treatment response?
- (2018) Stefan Garczyk et al. PLoS One
- Immunophenotypic profile as predictor of prognosis in advanced ovarian carcinoma
- (2018) Ako Yokoi BPh et al. HUMAN PATHOLOGY
- Prognostic impact of interleukin-6 expression in stage I ovarian clear cell carcinoma
- (2017) Ayako Kawabata et al. GYNECOLOGIC ONCOLOGY
- Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes
- (2017) Yi Kan Wang et al. NATURE GENETICS
- Low Arid1a Expression Correlates with Poor Prognosis and Promotes Cell Proliferation and Metastasis in Osteosarcoma
- (2017) Ning Xu et al. PATHOLOGY & ONCOLOGY RESEARCH
- Prevalence and prognostic role of mismatch repair gene defect in endometrial cancer patients
- (2017) Siriwan Tangjitgamol et al. TUMOR BIOLOGY
- Ovarian Clear Cell Carcinoma Sub-Typing by ARID1A Expression
- (2017) Jae Yoon Choi et al. YONSEI MEDICAL JOURNAL
- Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
- (2017) et al. JAMA Oncology
- Smoking may modify the association between neoadjuvant chemotherapy and survival from ovarian cancer
- (2016) Linda E. Kelemen et al. GYNECOLOGIC ONCOLOGY
- PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer
- (2016) John R. Webb et al. GYNECOLOGIC ONCOLOGY
- Various ARID1A expression patterns and their clinical significance in gastric cancers
- (2016) Young-Bae Kim et al. HUMAN PATHOLOGY
- An Immunohistochemical Algorithm for Ovarian Carcinoma Typing
- (2016) Martin Köbel et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Inactivating ARID1A Tumor Suppressor EnhancesTERTTranscription and Maintains Telomere Length in Cancer Cells
- (2016) Yohan Suryo Rahmanto et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Clinicopathologic Significance of HNF-1β, AIRD1A, and PIK3CA Expression in Ovarian Clear Cell Carcinoma
- (2016) Shuang Ye et al. MEDICINE
- ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice
- (2016) Radhika Mathur et al. NATURE GENETICS
- Loss of ARID1A expression predicts poor survival prognosis in gastric cancer: a systematic meta-analysis from 14 studies
- (2016) Lin Yang et al. Scientific Reports
- Loss of ARID1A Expression is Related to Gastric Cancer Progression, Epstein-Barr Virus Infection, and Mismatch Repair Deficiency
- (2016) Nayoung Han et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas
- (2015) M.K. McConechy et al. GYNECOLOGIC ONCOLOGY
- Loss of ARID1A expression is associated with poor prognosis in patients with stage I/II clear cell carcinoma of the ovary
- (2015) Hiroaki Itamochi et al. International Journal of Clinical Oncology
- TheARID1Apathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis
- (2015) Gautier Chene et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden
- (2015) Michael S Anglesio et al. JOURNAL OF PATHOLOGY
- Arid1ainactivation in anApc- andPten-defective mouse ovarian cancer model enhances epithelial differentiation and prolongs survival
- (2015) Yali Zhai et al. JOURNAL OF PATHOLOGY
- Synchronous Endometrial and Ovarian Carcinomas: Evidence of Clonality
- (2015) Michael S. Anglesio et al. JNCI-Journal of the National Cancer Institute
- ARID1A gene mutation in ovarian and endometrial cancers (Review)
- (2015) TAKASHI TAKEDA et al. ONCOLOGY REPORTS
- Coexistent ARID1A–PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling
- (2015) Ronald L. Chandler et al. Nature Communications
- Synchronous Endometrial and Ovarian Carcinomas: Evidence of Clonality
- (2015) Michael S. Anglesio et al. JNCI-Journal of the National Cancer Institute
- PD-1 and CD103 Are Widely Coexpressed on Prognostically Favorable Intraepithelial CD8 T Cells in Human Ovarian Cancer
- (2015) J. R. Webb et al. Cancer Immunology Research
- Loss of ARID1A Expression in Gastric Cancer: Correlation with Mismatch Repair Deficiency and Clinicopathologic Features
- (2015) Kyung-Ju Kim et al. Journal of Gastric Cancer
- Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
- (2014) P. Peterlongo et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Genomic Classification of Serous Ovarian Cancer with Adjacent Borderline Differentiates RAS Pathway and TP53-Mutant Tumors and Identifies NRAS as an Oncogenic Driver
- (2014) C. Emmanuel et al. CLINICAL CANCER RESEARCH
- Decreased ARID1A expression is correlated with chemoresistance in epithelial ovarian cancer
- (2014) Yoshihito Yokoyama et al. Journal of Gynecologic Oncology
- ARID1A is downregulated in non-small cell lung cancer and regulates cell proliferation and apoptosis
- (2014) Yi Zhang et al. TUMOR BIOLOGY
- Loss of ARID1A Expression Correlates With Stages of Tumor Progression in Uterine Endometrioid Carcinoma
- (2013) Tsui-Lien Mao et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- MMR deficiency is common in high-grade endometrioid carcinomas and is associated with an unfavorable outcome
- (2013) Gregg S. Nelson et al. GYNECOLOGIC ONCOLOGY
- Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study
- (2013) Weiva Sieh et al. LANCET ONCOLOGY
- ARID1A loss correlates with mismatch repair deficiency and intact p53 expression in high-grade endometrial carcinomas
- (2013) Ghassan Allo et al. MODERN PATHOLOGY
- Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations and ZNF217 amplification in ovarian clear cell carcinoma
- (2013) Hsien-Neng Huang et al. MODERN PATHOLOGY
- BAF complexes facilitate decatenation of DNA by topoisomerase IIα
- (2013) Emily C. Dykhuizen et al. NATURE
- Sun exposure and risk of epithelial ovarian cancer
- (2012) Clara Bodelon et al. CANCER CAUSES & CONTROL
- Aspirin, Nonaspirin Nonsteroidal Anti-inflammatory Drugs, or Acetaminophen and Risk of Ovarian Cancer
- (2012) Wei-Hsuan Lo-Ciganic et al. EPIDEMIOLOGY
- Loss of ARID1A Expression Is an Early Molecular Event in Tumor Progression From Ovarian Endometriotic Cyst to Clear Cell and Endometrioid Carcinoma
- (2012) Ayse Ayhan et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Architectural Patterns of Ovarian/Pelvic High-grade Serous Carcinoma
- (2012) Amy B. Bromley et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Mutation and Loss of Expression of ARID1A in Uterine Low-grade Endometrioid Carcinoma
- (2011) Bin Guan et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- The Breakthrough Generations Study: design of a long-term UK cohort study to investigate breast cancer aetiology
- (2011) A J Swerdlow et al. BRITISH JOURNAL OF CANCER
- ARID1A, a Factor That Promotes Formation of SWI/SNF-Mediated Chromatin Remodeling, Is a Tumor Suppressor in Gynecologic Cancers
- (2011) B. Guan et al. CANCER RESEARCH
- Loss of ARID1A-Associated Protein Expression is a Frequent Event in Clear Cell and Endometrioid Ovarian Cancers
- (2011) William J. Lowery et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas
- (2011) Melissa K McConechy et al. JOURNAL OF PATHOLOGY
- Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas
- (2011) Kimberly C Wiegand et al. JOURNAL OF PATHOLOGY
- A two-antibody mismatch repair protein immunohistochemistry screening approach for colorectal carcinomas, skin sebaceous tumors and gynecologic tract carcinomas
- (2011) Amirkaveh Mojtahed et al. MODERN PATHOLOGY
- Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma
- (2011) Atsuko Katagiri et al. MODERN PATHOLOGY
- Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer
- (2011) Kai Wang et al. NATURE GENETICS
- PIK3CA mutations and loss of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma
- (2011) Sohei Yamamoto et al. VIRCHOWS ARCHIV
- Clinicopathological Significance of Loss of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma
- (2010) Daichi Maeda et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Recruitment of newly diagnosed ovarian cancer patients proved challenging in a multicentre biobanking study
- (2010) Nyaladzi Balogun et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas
- (2010) Martin Köbel et al. JOURNAL OF PATHOLOGY
- Calculator for ovarian carcinoma subtype prediction
- (2010) Steve E Kalloger et al. MODERN PATHOLOGY
- ARID1AMutations in Endometriosis-Associated Ovarian Carcinomas
- (2010) Kimberly C. Wiegand et al. NEW ENGLAND JOURNAL OF MEDICINE
- Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
- (2010) Siân Jones et al. SCIENCE
- BRIT1/MCPH1 links chromatin remodelling to DNA damage response
- (2009) Guang Peng et al. NATURE CELL BIOLOGY
- The SWI/SNF complex and cancer
- (2009) D Reisman et al. ONCOGENE
- Genetic Polymorphisms in the Paraoxonase 1 Gene and Risk of Ovarian Epithelial Carcinoma
- (2008) G. Lurie et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Association of two common single-nucleotide polymorphisms in the CYP19A1 locus and ovarian cancer risk
- (2008) M. T Goodman et al. ENDOCRINE-RELATED CANCER
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started